Mirae Asset Global Investments
ELV icon

Mirae Asset Global Investments’s Elevance Health ELV Stock Holding History

Mirae Asset Global Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24M Buy
62,138
+10,906
+21% +$4.04M 0.04% 276
2026
Q1 		$15M Buy
51,232
+9,056
+21% +$2.98M 0.01% 327
2025
Q4 		$14.8M Buy
42,176
+2,686
+7% +$908K 0.04% 328
2025
Q3 		$12.8M Sell
39,490
-519
-1% -$161K 0.04% 331
2025
Q2 		$15.6M Buy
40,009
+2,154
+6% +$866K 0.05% 271
2025
Q1 		$16.4M Buy
37,855
+5,137
+16% +$2.06M 0.07% 219
2024
Q4 		$12.1M Sell
32,718
-2,164
-6% -$906K 0.05% 266
2024
Q3 		$18.3M Buy
34,882
+2,176
+7% +$1.16M 0.08% 176
2024
Q2 		$17.5M Sell
32,706
-41,510
-56% -$21.9M 0.09% 159
2024
Q1 		$36M Buy
74,216
+637
+0.9% +$317K 0.08% 244
2023
Q4 		$34.7M Sell
73,579
-188
-0.3% -$86.9K 0.07% 275
2023
Q3 		$32.2M Sell
73,767
-2,019
-3% -$916K 0.07% 279
2023
Q2 		$33.7M Sell
75,786
-22,366
-23% -$10.3M 0.07% 275
2023
Q1 		$45.1M Sell
98,152
-16,090
-14% -$7.66M 0.11% 194
2022
Q4 		$58.6M Buy
114,242
+19,752
+21% +$10M 0.15% 149
2022
Q3 		$43M Buy
94,490
+30,405
+47% +$14.5M 0.12% 193
2022
Q2 		$30.9M Buy
64,085
+11,157
+21% +$5.52M 0.08% 281
2022
Q1 		$26M Buy
52,928
+15,816
+43% +$7.23M 0.05% 362
2021
Q4 		$17.2M Sell
37,112
-9,126
-20% -$3.84M 0.04% 498
2021
Q3 		$17.2M Buy
46,238
+4,027
+10% +$1.53M 0.04% 448
2021
Q2 		$16.1M Buy
42,211
+4,038
+11% +$1.54M 0.05% 462
2021
Q1 		$13.7M Sell
38,173
-8,655
-18% -$2.78M 0.05% 443
2020
Q4 		$15M Buy
46,828
+8,318
+22% +$2.55M 0.06% 384
2020
Q3 		$10.3M Buy
38,510
+5,019
+15% +$1.35M 0.05% 378
2020
Q2 		$8.81M Sell
33,491
-11,972
-26% -$3.19M 0.05% 355
2020
Q1 		$10.3M Sell
45,463
-1,703
-4% -$464K 0.08% 265
2019
Q4 		$14.2M Buy
47,166
+1,138
+2% +$313K 0.09% 269
2019
Q3 		$11.1M Buy
46,028
+2,685
+6% +$736K 0.08% 286
2019
Q2 		$12.2M Buy
43,343
+4,252
+11% +$1.16M 0.08% 265
2019
Q1 		$11.2M Sell
39,091
-10,131
-21% -$2.93M 0.08% 235
2018
Q4 		$12.9M Buy
49,222
+3,752
+8% +$1.03M 0.12% 194
2018
Q3 		$12.4M Buy
45,470
+7,984
+21% +$2.07M 0.09% 224
2018
Q2 		$8.93M Sell
37,486
-9,507
-20% -$2.2M 0.12% 116
2018
Q1 		$10.3M Buy
46,993
+4,657
+11% +$1.09M 0.14% 107
2017
Q4 		$9.53M Buy
42,336
+9,335
+28% +$1.99M 0.13% 110
2017
Q3 		$6.27M Buy
33,001
+12,929
+64% +$2.46M 0.11% 143
2017
Q2 		$3.77M Sell
20,072
-3,723
-16% -$669K 0.07% 191
2017
Q1 		$3.94M Sell
23,795
-8,065
-25% -$1.28M 0.07% 173
2016
Q4 		$4.58M Sell
31,860
-6,051
-16% -$810K 0.1% 145
2016
Q3 		$4.75M Sell
37,911
-1,469
-4% -$190K 0.1% 133
2016
Q2 		$5.17M Sell
39,380
-9,000
-19% -$1.23M 0.13% 123
2016
Q1 		$6.72M Sell
48,380
-9,142
-16% -$1.22M 0.18% 99
2015
Q4 		$8.02M Buy
57,522
+4,244
+8% +$585K 0.27% 89
2015
Q3 		$7.46M Sell
53,278
-1,132
-2% -$170K 0.31% 78
2015
Q2 		$8.93M Buy
+54,410
New +$8.69M 0.29% 76

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Mirae Asset Global Investments's ELV Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Elevance Health (ELV) stake by 21% in Q2 2026, buying an estimated $4.04M and bringing the position to 62,138 shares worth $24M. The position accounts for 0.04% of the portfolio, ranked #276.

Mirae Asset Global Investments first reported a position in ELV in Q2 2015 and has held it in 45 quarters since. The position peaked at $58.6M in Q4 2022. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mirae Asset Global Investments held 62,138 shares of Elevance Health worth $24M as of Q2 2026.
  • Mirae Asset Global Investments bought 10,906 Elevance Health shares in Q2 2026, an estimated $4.04M.
  • Elevance Health made up 0.04% of Mirae Asset Global Investments's portfolio in Q2 2026, its #276 holding.
  • Mirae Asset Global Investments first reported a position in Elevance Health in Q2 2015 and has held it in 45 quarters since.
  • Mirae Asset Global Investments's Elevance Health position peaked at $58.6M in Q4 2022.
  • 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.